Bear Mountain Capital »

Crispr Therapeutics shares owned by Bear Mountain Capital

Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Bear Mountain Capital from 13F filings

Historical chart of Bear Mountain Capital investment in Crispr Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Crispr Therapeutics held by Bear Mountain Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Crispr Therapeutics by Bear Mountain Capital

Quarter filed Position value Share count Share price at filing
2025-09-30 $433 6 72.33

More positions owned by Bear Mountain Capital

Vanguard Mid Cap Etf (VO)
Vanguard S&p 500 Etf Etf (VOO)
Ishares Amt-free Muni Bond Etf Etf (MUB)
Vanguard Ftse Developed Markets Etf Etf (VEA)
Ishares Msci Eafe Small Cap Etf Etf (SCZ)
Vanguard Short-term Corporate Bond Etf Etf (VCSH)
Vanguard Total Bond Market Etf Etf (BND)
Vanguard Ftse Emerging Markets Etf Etf (VWO)
Vanguard Small Cap Etf Etf (VB)
Vanguard Real Estate Etf Etf (VNQ)
Vanguard Total International Bond Etf Etf (BNDX)
Ishares Core S&p 500 Etf Etf (IVV)
Ishares Esg Optimized Msci Usa Etf Etf (SUSA)
Vanguard Total Stock Market Etf Etf (VTI)
Ishares Esg Aware 1-5 Year Usd Corporate Bond Etf Etf (SUSB)

View all positions for Bear Mountain Capital

Top funds holding Crispr Therapeutics

ARK Investment Management
BlackRock
Capital Research and Management Company - Division 3
Orbis Allan Gray
State Street Corporation
T. Rowe Price Investment Management
UBS Group
Vanguard Group
Sumitomo Mitsui Trust Holdings
Nikko Asset Management Americas
Geode Capital Management
Susquehanna International
Sr One Capital Management
Citadel Advisors
FMR

View all funds holding Crispr Therapeutics